Small Companies to Share £2.5M in new Government Investment to Develop Industrial Biotechnology Processes
News Mar 12, 2010
The government has announced that it is to invest £2.5 million to stimulate innovation in the UK’s industrial biotechnology sector, with most of the funding going to small and medium-sized companies.
The investment will be made in nineteen feasibility studies, all of which will be led by small and medium-sized British companies. A total of nearly 40 organizations, including many universities, will take part in the studies and receive financial support. The funding, from the Department for Business, Innovation and Skills (BIS), follows the conclusion of a funding competition managed on behalf of BIS by the Technology Strategy Board.
The funding for the feasibility studies was announced today by Ian Lucas MP, Minister for Business and Regulatory Reform, during a visit to the Centre for Process Innovation in Wilton, Teesside.
The Business Minister said: “These projects have a license to innovate. They will look at how industrial biotechnology can be competitively applied to the production of high value chemicals. These could replace petrochemical-derived products, or use micro-organisms to create bio-based products to improve health and nutrition. But with nearly 40 businesses, universities and research organizations getting their heads together, we can guarantee some fascinating results.”
Commenting on the results of the investment funding competition, Merlin Goldman, the Technology Strategy Board’s Lead Technologist for the Biosciences, said: “We were delighted by the high quality of applications received. With nearly two-thirds of commercial innovation stemming from small companies, they are a vital source of wealth-generating new products, materials and processes. Many small companies working in this sector have great ideas, but lack the funds and facilities to enable them to carry out the important development and demonstration feasibility work required.
“We anticipate that the results of these feasibility projects will lead to commercial-scale activities within 1 to 2 years.”
Applications addressed by the feasibility studies may relate to, for example, novel bio-based products to improve health and nutrition, as well as energy and water usage, and bio-based chemicals and materials to make a wide range of products such as medical devices, paints and personal care items.
Due to the high quality of the proposals to be funded, it is expected that a high proportion of the SMEs leading the projects will succeed in demonstrating the technical feasibility of their ideas. These companies are then likely to seek additional investment, from the Technology Strategy Board or other sources, to demonstrate the technical and economic feasibility of their processes on a commercial scale.
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
'Body-on-a-Chip' Could Advance Drug EvaluationNews
MIT engineers have developed new technology that could be used to evaluate new drugs and detect possible side effects before the drugs are tested in humans. Using a microfluidic platform that connects engineered tissues from up to 10 organs, the researchers can accurately replicate human organ interactions for weeks at a time.READ MORE
Hope for Hot Flushes: New Class of Menopause Drugs Reduces SeverityNews
A new class of experimental drugs reduces hot flushes in menopausal women by almost three-quarters in just three days. The new analysis, published in the journal Menopause, also revealed sleep and concentration significantly improved in the three-day window.